More information regarding Humana is available to investors via the
Investor Relations page of the company's web site at http://www.

Conferences sponsored by the European Public Choice Society

sciences presented

humana.com ,
including copies of:
- Annual report to stockholders;
- Securities and Exchange Commission filings;
- Most recent investor conference presentation;
- Quarterly earnings news releases;
- Replay of most recent earnings release conference call;
- Calendar of events (includes upcoming earnings conference call dates,
times, and access number, as well as planned interaction with
institutional investors);
- Corporate Governance information. Presented by Prof.

epcs aarhus

, Humana Inc. No password is required. As is the case with all biopharmaceutical products under
development, results from future studies with more data may show less
favourable outcomes.m.

2002 social

Humana Inc. Robert Dreicer , Cleveland
Clinic Foundation, Cleveland, Ohio. The
results of clinical testing to date are preliminary and based upon a small
number of patients. - 9:45 a.

2002 2001

SBS is a European commercial television and radio broadcasting company
with operations in Western and Central Europe .

2002 choice

All parties interested in listening to the audio only portion of the
presentation are invited to dial 888-625-7430. Telephone replays will be available from 2:00 p. Thierry
Velu, Academic Erasme Hospital, Brussels, Belgium.

economics aarhus

m.

2.

papers 2002

eastern time.

presented epcs

Over its 44-year history, Humana has consistently seized opportunities to
meet changing customer needs.

aarhus 2001

The meeting will take place
in Orlando, Florida, May 13-17, 2005 .

lago economics

humana. The company suggests web
participants sign on approximately 15 minutes in advance of the scheduled
meeting time. Poster presentation: "A Phase II study evaluating the clinical
efficacy of MVA-MUC1-IL2 (TG4010) in association with chemotherapy in
patients with Non Small Cell Lung Cancer".
Harry Evans Sloan, Executive Chairman is scheduled to present on
Wednesday , May 18, 2005 from 9:00 a.

2001 2002

The company also suggests web participants visit the site well
in advance of the meeting to run a system test and to download any free
software needed to view the presentation .
For those unable to listen to the live event, the virtual presentation
archive will be available in the Presentations section of the Investor
Relations page at http://www.com , approximately two hours following the live
webcast. Presented by Dr. "It will be an opportunity to communicate updated ,
additional data beyond the promising interim results that we have released up
to now.

2002 sponsored

This press release contains a forward-looking statement regarding the
potential efficacy of one of Transgene's cancer vaccine candidates. Countries where SBS currently
has broadcasting assets include: Belgium (Flanders), Denmark, Finland, Greece,
Hungary, The Netherlands, Norway, Romania and Sweden.

paris epcs

The live virtual presentation (audio with slides) may be accessed via
Humana's Investor Relations page at http://www.

participants papers

conferences maggiore

"We are very pleased that two abstracts describing clinical results with
our cancer vaccine MVA-MUC1-IL2 have been selected for presentation at this
year's ASCO meeting," said Dr.sbsbroadcasting.

held annual

The company will webcast the shareholders '
meeting and related slide presentation for those unable to attend the event in
person. The
company suggests participants dial in approximately ten minutes in advance of
the scheduled meeting time . eastern time on
April 26, 2005 until midnight eastern time on May 3, 2005 and can be accessed
by dialing 800-642-1687 and providing the conference ID #4669212.humana.

1.

SBS Broadcasting to Present at the Bear Stearns 14th Annual Global Credit Conference

lago annual

aarhus belgirate

LOUISVILLE, Ky . Patrick Squiban, MD, VP, Medical and Regulatory
Affairs of Transgene.

choice annual

Today, the company is a leader in consumer
engagement, providing guidance that leads to lower costs and a better health
plan experience throughout its diversified customer portfolio. LUXEMBOURG, SBS Broadcasting SA
(Nasdaq: SBTV; Euronext Amsterdam N.m.

For further information visit: http://www.

denmark conferences

A webcast of
the presentation will not be provided for this conference.

italy participants

Humana Inc. to Hold Annual Shareholders' Meeting on April 26 2005

com .com.

belgirate european

m.
Humana offers a diversified portfolio of health insurance products and related
services -- through traditional and consumer-choice plans -- to employer
groups, government -sponsored plans, and individuals.

papers maggiore

Oral presentation in the genito-urinary scientific program: "MVA-MUC1 -
IL2 vaccine immunotherapy (TG4010) in patients with prostate cancer
with biochemical failure"."

About Transgene:
Transgene, based in Strasbourg, France, is a biopharmaceutical company
dedicated to the discovery and development of therapeutic vaccines and
immunotherapy products for the treatment of cancer and infectious diseases.
Transgene has a broad portfolio of products in clinical development.V. Eastern Time.